Literature DB >> 27185864

Cdk-dependent phosphorylation regulates TRF1 recruitment to PML bodies and promotes C-circle production in ALT cells.

Florence R Wilson1, Angus Ho2, John R Walker2, Xu-Dong Zhu1.   

Abstract

TRF1, a duplex telomeric DNA binding protein, is implicated in homologous-recombination-based alternative lengthening of telomeres, known as ALT. However, how TRF1 promotes ALT activity has yet to be fully characterized. Here we report that Cdk-dependent TRF1 phosphorylation on T371 acts as a switch to create a pool of TRF1, referred to as (pT371)TRF1, which is recruited to ALT-associated PML bodies (APBs) in S and G2 phases independently of its binding to telomeric DNA. We find that phosphorylation of T371 is essential for APB formation and C-circle production, both of which are hallmarks of ALT. We show that the interaction of (pT371)TRF1 with APBs is dependent upon ATM and homologous-recombination-promoting factors Mre11 and BRCA1. In addition, (pT371)TRF1 interaction with APBs is sensitive to transcription inhibition, which also reduces DNA damage at telomeres. Furthermore, overexpression of RNaseH1 impairs (pT371)TRF1 recruitment to APBs in the presence of campothecin, an inhibitor that prevents topoisomerase I from resolving RNA-DNA hybrids. These results suggest that transcription-associated DNA damage, perhaps arising from processing RNA-DNA hybrids at telomeres, triggers (pT371)TRF1 recruitment to APBs to facilitate ALT activity.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  ALT; Cdk; PML bodies; TRF1

Mesh:

Substances:

Year:  2016        PMID: 27185864     DOI: 10.1242/jcs.186098

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.

Authors:  Angus Ho; Florence R Wilson; Stephanie L Peragine; Kajaparan Jeyanthan; Taylor R H Mitchell; Xu-Dong Zhu
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

2.  ATM and CDK2 control chromatin remodeler CSB to inhibit RIF1 in DSB repair pathway choice.

Authors:  Nicole L Batenburg; John R Walker; Sylvie M Noordermeer; Nathalie Moatti; Daniel Durocher; Xu-Dong Zhu
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

Review 3.  Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?

Authors:  Luca Pompili; Carlo Leonetti; Annamaria Biroccio; Erica Salvati
Journal:  J Exp Clin Cancer Res       Date:  2017-12-22

4.  Identification of Key Proteins from the Alternative Lengthening of Telomeres-Associated Promyelocytic Leukemia Nuclear Bodies Pathway.

Authors:  Isaac Armendáriz-Castillo; Katherine Hidalgo-Fernández; Andy Pérez-Villa; Jennyfer M García-Cárdenas; Andrés López-Cortés; Santiago Guerrero
Journal:  Biology (Basel)       Date:  2022-01-25

5.  CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection.

Authors:  Nicole L Batenburg; John R Walker; Yan Coulombe; Alana Sherker; Jean-Yves Masson; Xu-Dong Zhu
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

6.  The Winged Helix Domain of CSB Regulates RNAPII Occupancy at Promoter Proximal Pause Sites.

Authors:  Nicole L Batenburg; Shixin Cui; John R Walker; Herb E Schellhorn; Xu-Dong Zhu
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

7.  The Role of Non-Specific Interactions in Canonical and ALT-Associated PML-Bodies Formation and Dynamics.

Authors:  Alexander V Fonin; Sergey A Silonov; Olesya G Shpironok; Iuliia A Antifeeva; Alexey V Petukhov; Anna E Romanovich; Irina M Kuznetsova; Vladimir N Uversky; Konstantin K Turoverov
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

8.  Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells.

Authors:  Nicole L Batenburg; Sofiane Y Mersaoui; John R Walker; Yan Coulombe; Ian Hammond-Martel; Hugo Wurtele; Jean-Yves Masson; Xu-Dong Zhu
Journal:  Nucleic Acids Res       Date:  2021-12-16       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.